期刊文献+

一氧化氮对慢性病贫血大鼠铁代谢影响 被引量:6

Effect of Nitric Oxide on Iron Metabolism in Rats with Anemia of Chronic Disease
下载PDF
导出
摘要 本研究探讨一氧化氮 (NO)在慢性病贫血 (ACD)发病中的作用及对铁代谢影响的机制 ,为ACD的防治提供实验依据。在建立传统的类风湿性关节炎大鼠动物模型的基础上 ,通过反复注射弗氏完全佐剂 ,建立ACD大鼠动物模型。利用此模型观察不同处理组NO浓度的改变与贫血及铁代谢的关系。结果表明 :ACD组血清NO浓度和一氧化氮合酶 (NOS)活性显著增高 ,贫血明显 ,血清铁、总铁结合力、转铁蛋白饱和度、红细胞内铁蛋白、骨髓血细胞转铁蛋白受体、骨髓内铁及肝脏顺乌头酸酶活性降低 ,血清铁蛋白及肝脏储铁增加 ,与对照组比较差异显著 ;用NOS抑制剂后 ,NO和NOS水平降低 ,贫血改善 ,铁代谢指标介于ACD与正常对照组之间 ,统计学处理有显著性差异。结论 :NO参与了ACD的发病及ACD时铁代谢的调节 ,为从NO对铁代谢影响角度进一步认识ACD的发病机制提供了实验依据 ;及早降低NO水平 ,有利于阻止贫血的发展 。 To explore the role of nitric oxide (NO) in the pathogenesis and effect on regulation of iron metabolism in anemia of chronic disease (ACD) and provide experimental evidence for prevention and treatment of ACD. On the basis of traditional animal model of rheumatoid arthritis, an ACD rat model was established by repeated injection of Freund′s complete adjuvant. The relationship between NO concentration and iron metabolism was observed in ACD rats with and without NO synthase inhibitor, L NAME, (N ω nitro L arginine methyl ester L NAME). The results showed that anemia was induced in the rat model. In the ACD group, NO concentration and NO synthase activity in serum increased; iron, total iron binding capacity (TIBC) and transferrin saturation (TS) in serum and ferritin in erythrocytes (rFn) decreased; transferrin receptor (TfR) and iron in bone marrow cells decreased; ferritin in serum and iron in liver increased and meanwhile the acotinase activity in liver decreased. After administration of L NAME, anemia was improved, when NO, NO synthase activity, liver iron and serum ferritin decreased, but serum iron, TS, TIBC, rFn, TfR, iron in marrow cells and liver acotinase activity elevated. The levels of parameters for iron metabolism in ACD+L NAME group were situated between ACD and control groups. It is concluded that NO palys an important role in pathogenesis of ACD and influences the regulation of iron in ACD. Decrease of NO level as early as possible will benefit to block the development of anemia, that will provide a new strategy of therapy for ACD.
作者 王强 廖清奎
出处 《中国实验血液学杂志》 CAS CSCD 2003年第4期385-389,共5页 Journal of Experimental Hematology
基金 纽约中华医学基金会资助
关键词 一氧化氮 慢性病贫血 铁代谢 nitric oxide anemia of chronic disease iron metabolism
  • 相关文献

参考文献2

二级参考文献3

  • 1Guo B,J Biol Chem,1995年,270卷,16529页 被引量:1
  • 2Tang C K,J Biol Chem,1992年,267卷,24466页 被引量:1
  • 3廖清奎,中华血液学杂志,1990年,11卷,156页 被引量:1

共引文献54

同被引文献44

  • 1田德安,洪捷敏,刘南植,王家.一氧化氮合酶抑制剂对酒精性脂肪肝大鼠肝组织氧化抗氧化系统的影响[J].中华肝脏病杂志,2004,12(10):608-608. 被引量:3
  • 2金镇,王景华,李守柔,曲陆荣,李之芬,丁惠,金秀华.正常妊娠和妊高征孕妇血浆一氧化氮的变化[J].中华妇产科杂志,1996,31(10):594-596. 被引量:24
  • 3Richardson DR,Ponka P.The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.Biochim Biophys Acta,1997; 1331:1 -40 被引量:1
  • 4Cabantchik ZI,Glickstein H,Milgram P,et al.A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells.Anal Biochem,1996; 233:221 -227 被引量:1
  • 5Epsztejn S,Kakhlon O,Glickstein H,et al.Fluorescence analysis of the labile iron pool of mammalian cells.Anal Biochem,1997;248:31 -40 被引量:1
  • 6Roy CN,Blemings KP,Deck KM,etal.Increased IRP1 and IRP2RNA binding activity accompanies a reduction of the labile iron pool in HFE-expressing cells.J Cell Physiol,2002; 190:218 -226 被引量:1
  • 7Kakhlon O,Cabantchik ZI.The labile iron pool:characterization,measurement,and participation in cellular processes (1).Free Radic Biol Med,2002; 33:1037-1046 被引量:1
  • 8Buss JL,Torti FM,Torti SV.The role of iron chelation in cancer therapy.Curr Med Chem,2003; 10:1021-1034 被引量:1
  • 9Richardson DR.Potential of iron chelators as effective antiproliferative agents.Can J Physiol Pharmacol,1997; 75:1164 -1180 被引量:1
  • 10Joseph J.Mazza.Anemia of Chronic Disease.Manual of Clinical Hematology,2002;04:8-25. 被引量:1

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部